As diabetes care continues to be a significant focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy evolution in incretin mimetic medications. While all work to https://my-social-box.com/story7669013/retatrutid-vs-that-medication-vs-semaglutide-a-direct-comparison